1,3,4-oxadiazole has been researched along with pyrimidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J; Feng, L; He, H; Peng, H; Ren, Y; Wang, W; Xia, Q; Zhou, Y | 1 |
| Babu, BN; Kaki, VR; Kiranmai, G; Makhal, PN; Nagesh, N; Parimala Devi, G; Shaikh, AS; Shankaraiah, N; Sigalapalli, DK; Tangellamudi, ND; Tokala, R | 1 |
2 other study(ies) available for 1,3,4-oxadiazole and pyrimidine
| Article | Year |
|---|---|
Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cyanobacteria; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Escherichia coli; Fungi; Molecular Structure; Oxadiazoles; Pyrimidines; Pyruvate Dehydrogenase (Lipoamide); Structure-Activity Relationship | 2016 |
Exploration of mercaptoacetamide-linked pyrimidine-1,3,4-oxadiazole derivatives as DNA intercalative topo II inhibitors: Cytotoxicity and apoptosis induction.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Pyrimidines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2022 |